A functional variomics tool for discovering drug-resistance genes and drug targets.

TitleA functional variomics tool for discovering drug-resistance genes and drug targets.
Publication TypeJournal Article
Year of Publication2013
AuthorsHuang, Z, Chen, K, Zhang, J, Li, Y, Wang, H, Cui, D, Tang, J, Liu, Y, Shi, X, Li, W, Liu, D, Chen, R, Sucgang, RS, Pan, X
JournalCell Rep
Volume3
Issue2
Pagination577-85
Date Published2013 Feb 21
ISSN2211-1247
KeywordsAlleles, Amphotericin B, Antifungal Agents, Cell Cycle Proteins, Cycloheximide, Drug Resistance, Microbial, Mutation, Phosphatidylinositol 3-Kinases, Phosphoinositide-3 Kinase Inhibitors, Proteolipids, Ribosomal Proteins, Saccharomyces cerevisiae, Saccharomyces cerevisiae Proteins, Sirolimus
Abstract

Comprehensive discovery of genetic mechanisms of drug resistance and identification of in vivo drug targets represent significant challenges. Here we present a functional variomics technology in the model organism Saccharomyces cerevisiae. This tool analyzes numerous genetic variants and effectively tackles both problems simultaneously. Using this tool, we discovered almost all genes that, due to mutations or modest overexpression, confer resistance to rapamycin, cycloheximide, and amphotericin B. Most significant among the resistance genes were drug targets, including multiple targets of a given drug. With amphotericin B, we discovered the highly conserved membrane protein Pmp3 as a potent resistance factor and a possible target. Widespread application of this tool should allow rapid identification of conserved resistance mechanisms and targets of many more compounds. New genes and alleles that confer resistance to other stresses can also be discovered. Similar tools in other systems, such as human cell lines, will also be useful.

DOI10.1016/j.celrep.2013.01.019
Alternate JournalCell Rep
PubMed ID23416056
PubMed Central IDPMC3594652
Grant List1S10RR026550 / RR / NCRR NIH HHS / United States
F32 EY019430 / EY / NEI NIH HHS / United States
F32EY19430 / EY / NEI NIH HHS / United States
P30CA125123 / CA / NCI NIH HHS / United States
P30 HD024064 / HD / NICHD NIH HHS / United States
S10 RR026550 / RR / NCRR NIH HHS / United States
P30 CA125123 / CA / NCI NIH HHS / United States
P30HD024064 / HD / NICHD NIH HHS / United States
HG004840 / HG / NHGRI NIH HHS / United States
R01 HG004840 / HG / NHGRI NIH HHS / United States

Similar Publications

Fiziev PP, McRae J, Ulirsch JC, Dron JS, Hamp T, Yang Y, et al.. Rare penetrant mutations confer severe risk of common diseases. Science. 2023;380(6648):eabo1131.
Elbendary HM, Marafi D, Saad AK, Elhossini R, Duan R, Rafat K, et al.. Novel LSS variants in alopecia and intellectual disability syndrome: New case report and clinical spectrum of LSS-related rare disease traits. Clin Genet. 2023;104(3):344-349.
Weinstock JS, Laurie CA, Broome JG, Taylor KD, Guo X, Shuldiner AR, et al.. The genetic determinants of recurrent somatic mutations in 43,693 blood genomes. Sci Adv. 2023;9(17):eabm4945.
Lecca M, Pehlivan D, Suñer DHeine, Weiss K, Coste T, Zweier M, et al.. Bi-allelic variants in the ESAM tight-junction gene cause a neurodevelopmental disorder associated with fetal intracranial hemorrhage. Am J Hum Genet. 2023;110(4):681-690.
Weinstock JS, Gopakumar J, Burugula BBharathi, Uddin MMesbah, Jahn N, Belk JA, et al.. Aberrant activation of TCL1A promotes stem cell expansion in clonal haematopoiesis. Nature. 2023;616(7958):755-763.
Calame DG, Vadillo CMoreno, Berger S, Lotze T, Shinawi M, Poupak J, et al.. Cation leak through the ATP1A3 pump causes spasticity and intellectual disability. Brain. 2023;146(8):3162-3171.
F Frost G, Morimoto M, Sharma P, Ruaud L, Belnap N, Calame DG, et al.. Bi-allelic SNAPC4 variants dysregulate global alternative splicing and lead to neuroregression and progressive spastic paraparesis. Am J Hum Genet. 2023;110(4):663-680.
Hussain HMuhammad J, Wang M, Huang A, Schmidt R, Qian X, Yang P, et al.. Novel Pathogenic Mutations Identified from Whole-Genome Sequencing in Unsolved Cases of Patients Affected with Inherited Retinal Diseases. Genes (Basel). 2023;14(2).
Saffari A, Lau T, Tajsharghi H, Karimiani EGhayoor, Kariminejad A, Efthymiou S, et al.. The clinical and genetic spectrum of autosomal-recessive TOR1A-related disorders. Brain. 2023;146(8):3273-3288.
Wen S, Wang M, Qian X, Li Y, Wang K, Choi J, et al.. Systematic assessment of the contribution of structural variants to inherited retinal diseases. Hum Mol Genet. 2023;32(12):2005-2015.